Feasibility Trial to Maintain Normal Cerebral Oxygen Saturation in High-Risk Cardiac Surgery (Tête-à-coeur)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Using the brain and the heart as index organs, perioperative interventions to optimize cerebral oxygen saturation and cardiac contractility in high-risk patients undergoing cardiac surgery should have a beneficial systemic effect for enhancing global tissue perfusion and improve outcomes.
| Condition | Intervention |
|---|---|
|
Cerebral Hypoxia |
Procedure: strategies to reverse decrease in rSO2 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Prevention |
| Official Title: | Perioperative Interventions to Optimize Cerebral Oxygen Saturation (rSO2) in High-risk Patients Undergoing Cardiac Surgery Should Have a Beneficial Systemic Effect for Enhancing Global Tissue Perfusion and Improve Outcomes. |
- Perioperative complications [ Time Frame: Up to 24 hours ] [ Designated as safety issue: No ]-new, persistent Q-wave myocardial infarction
- First 30 days post-operative outcomes [ Time Frame: 30 days ] [ Designated as safety issue: No ]
- readmission to hospital within 30 days
- death
- ICU data [ Time Frame: Up to 48 hours ] [ Designated as safety issue: No ]
- ICU admission and discharge times
- tracheal extubation time in hours
- First 24 hours complications [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
- clinical stroke manifested as focal neurological deficit persisting 24hr and confirmed by brain computed tomography imaging
- prolonged ventilation defined as extubation at > 24 h postoperatively
- Post-operative complications [ Time Frame: Up to 7 days ] [ Designated as safety issue: No ]
- renal failure as defined by the RIFLE criteria
- reoperation for any cause
- arrhythmia requiring treatment
- Hospital length of stay
- wound infection requiring specific antibiotic coverage
| Estimated Enrollment: | 200 |
| Study Start Date: | July 2010 |
| Estimated Study Completion Date: | September 2013 |
| Primary Completion Date: | July 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: Intervention
an alarm threshold at a value of 90% of the resting baseline cerebral saturation value (baseline - 10%) will be established. To minimize the probability of patients reaching significant decreases rSO2 values, interventions to improve cerebral oxygenation will be initiated according to the strategies described in the algorithm. The success and failure of these interventions will be noted. As in the Control group, the screen will remain blinded in the ICU and the intensivist will not see the values.
|
Procedure: strategies to reverse decrease in rSO2
an alarm threshold at a value of 90% of the resting baseline cerebral saturation value (baseline - 10%) will be established. To minimize the probability of patients reaching significant decreases rSO2 values, interventions to improve cerebral oxygenation will be initiated according to the strategies described in the algorithm. The success and failure of these interventions will be noted. As in the Control group, the screen will remain blinded in the ICU and the intensivist will not see the values.
Other Name: Cerebral Oxymetry decrease
|
|
No Intervention: Control
the cerebral oxymetry screen will be blinded and changes in NIRS values will be unknown to the anesthesiologist. The management of the case will proceed as per normal local practice. The screen will remain blinded in the ICU and the intensivist will not see the values.
|
Detailed Description:
The proportion of high-risk patients requiring cardiac surgery and of high-risk cardiac surgeries is increasing. These populations of patients are at increased risk of perioperative morbidity and mortality. Transesophageal echocardiography (TEE) evaluation in cardiac surgery has been shown to impact on the perioperative management of patients and to improve outcomes. Near infrared-reflectance spectroscopy (NIRS) is a technique that has been employed since the mid-1970's and that can be used as a non-invasive and continuous monitor of the balance between cerebral oxygen delivery and consumption. Two recent randomized trials have shown an association between correction of cerebral desaturation and shorter recovery room and hospital stay in non-cardiac surgery, and with a decrease in major organ dysfunction and in intensive care length of stay after coronary artery bypass. By combining NIRS and TEE in high-risk patients, optimal tissue perfusion could be achieved and perioperative morbidity and mortality could be reduced.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients with EUROSCORES ≥ 10.
- Planned complex surgery including more than one procedure, or redo procedures.
- Patient able to read and understand the consent form.
- Patients ≥ 18 years of age.
Exclusion Criteria:
- High risk patients undergoing of off pump coronary artery bypass.
- Emergency surgeries less than 6 hours from diagnosis.
- Patient unable to read and understand the consent form.
- Patients with and IABP or a ventricular assist device
- Planned circulatory arrest
- Planned surgery of the descending aorta.
- Patients with acute endocarditis.
Contacts and Locations| Contact: Jonathan Lacharite, RRT | 514-376-3330 ext 3725 | jonathan.lacharite@icm-mhi.org |
| Contact: Alain Deschamps, MD, FRCPC | 514-376-3330 ext 3732 | a.deschamps@umontreal.ca |
| Canada, Quebec | |
| Montreal Heart Institute | Recruiting |
| Montreal, Quebec, Canada, H1T 1C8 | |
| Contact: Jonathan Lacharite, RRT 514-376-3330 ext 3725 jonathan.lacharite@icm-mhi.org | |
| Contact: Micheline Roy, RRT, CCRP 514-376-3330 ext 3725 micheline.roy@icm-mhi.org | |
| Principal Investigator: Alain Deschamps, MD, FRCPC | |
| Principal Investigator: | Alain Deschamps, MD, FRCPC | Montreal Heart Institute |
More Information
Publications:
| Responsible Party: | Alain Deschamps, PhD, MD, FRCPC,, Montreal Heart Institute |
| ClinicalTrials.gov Identifier: | NCT01432184 History of Changes |
| Other Study ID Numbers: | ICM 08-1009 |
| Study First Received: | August 26, 2011 |
| Last Updated: | April 23, 2013 |
| Health Authority: | Canada: Health Canada |
Keywords provided by Montreal Heart Institute:
|
cerebral hypoxia |
Additional relevant MeSH terms:
|
Anoxia Hypoxia, Brain Signs and Symptoms, Respiratory Signs and Symptoms |
Brain Diseases Central Nervous System Diseases Nervous System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013